302 related articles for article (PubMed ID: 31658258)
1. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
[TBL] [Abstract][Full Text] [Related]
2. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
[TBL] [Abstract][Full Text] [Related]
3. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
Odonkor M; Naufal F; Munoz B; Mkocha H; Kasubi M; Wolle M; West S
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009343. PubMed ID: 33861754
[TBL] [Abstract][Full Text] [Related]
4. Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea.
Macleod CK; Butcher R; Javati S; Gwyn S; Jonduo M; Abdad MY; Roberts CH; Keys D; Koim SP; Ko R; Garap J; Pahau D; Houinei W; Martin DL; Pomat WS; Solomon AW
Clin Infect Dis; 2021 Feb; 72(3):423-430. PubMed ID: 31965155
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
Cama A; Müller A; Taoaba R; Butcher RMR; Itibita I; Migchelsen SJ; Kiauea T; Pickering H; Willis R; Roberts CH; Bakhtiari A; Le Mesurier RT; Alexander NDE; Martin DL; Tekeraoi R; Solomon AW;
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
[TBL] [Abstract][Full Text] [Related]
6. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.
Senyonjo LG; Debrah O; Martin DL; Asante-Poku A; Migchelsen SJ; Gwyn S; deSouza DK; Solomon AW; Agyemang D; Biritwum-Kwadwo N; Marfo B; Bakajika D; Mensah EO; Aboe A; Koroma J; Addy J; Bailey R
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007027. PubMed ID: 30550537
[TBL] [Abstract][Full Text] [Related]
7. Serology for trachoma surveillance after cessation of mass drug administration.
Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
[TBL] [Abstract][Full Text] [Related]
8. Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation.
West SK; Zambrano AI; Sharma S; Mishra SK; Muñoz BE; Dize L; Crowley K; Gaydos CA; Rotondo LA
JAMA Ophthalmol; 2017 Nov; 135(11):1141-1146. PubMed ID: 28973295
[TBL] [Abstract][Full Text] [Related]
9. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
[TBL] [Abstract][Full Text] [Related]
10. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
[TBL] [Abstract][Full Text] [Related]
11. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
Lee JS; Muñoz BE; Mkocha H; Gaydos CA; Quinn TC; West SK
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392
[TBL] [Abstract][Full Text] [Related]
12. Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma.
Butcher R; Handley B; Garae M; Taoaba R; Pickering H; Bong A; Sokana O; Burton MJ; Sepúlveda N; Cama A; Mesurier RL; Solomon AW; Mabey D; Taleo F; Tekeraoi R; Roberts CH
J Infect; 2020 Apr; 80(4):454-461. PubMed ID: 32017971
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana.
Senyonjo L; Addy J; Martin DL; Agyemang D; Yeboah-Manu D; Gwyn S; Marfo B; Asante-Poku A; Aboe A; Mensah E; Solomon AW; Bailey RL
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009744. PubMed ID: 34543293
[TBL] [Abstract][Full Text] [Related]
14. Population-Based Prevalence of
Nash SD; Astale T; Nute AW; Bethea D; Chernet A; Sata E; Zerihun M; Gessese D; Ayenew G; Ayele Z; Melak B; Haile M; Zeru T; Tadesse Z; Arnold BF; Callahan EK; Martin DL
Am J Trop Med Hyg; 2021 Jan; 104(1):207-215. PubMed ID: 33200728
[TBL] [Abstract][Full Text] [Related]
15. The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children.
West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
Sci Rep; 2020 Sep; 10(1):15225. PubMed ID: 32938957
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of
Gwyn SE; Xiang L; Kandel RP; Dean D; Gambhir M; Martin DL
Am J Trop Med Hyg; 2018 Jan; 98(1):216-220. PubMed ID: 29141720
[TBL] [Abstract][Full Text] [Related]
17. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
[TBL] [Abstract][Full Text] [Related]
18. Wait and watch: A trachoma surveillance strategy from Amhara region, Ethiopia.
Sata E; Seife F; Ayele Z; Murray SA; Wickens K; Le P; Zerihun M; Melak B; Chernet A; Jensen KA; Gessese D; Zeru T; Dawed AA; Debebe H; Tadesse Z; Callahan EK; Martin DL; Nash SD
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011986. PubMed ID: 38386689
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
[TBL] [Abstract][Full Text] [Related]
20. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Oldenburg CE
Ophthalmic Epidemiol; 2019 Aug; 26(4):231-237. PubMed ID: 30957594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
